Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01124292 · ClinicalTrials.gov registry record · Phase 1

Evaluation of a Tongue Operated Assistive Technology for Individuals With Severe Paralysis

A Phase 1 study, sponsored by Georgia Institute of Technology.

Completed
Registry status
Phase 1
Development phase
61
Enrollment target

NCT01124292 is a Phase 1 study that has completed, run by Georgia Institute of Technology. The registered enrollment target is 61 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01124292, a Phase 1 study, has completed, sponsored by Georgia Institute of Technology.

COMPLETED
Registry status
Phase 1
Development phase
61 participants
Enrollment target

Study Summary

This study was intended to evaluate a new assistive neuro-technology, known as the Tongue Drive System (TDS), by its potential end-users, i.e. individuals with severe disabilities, who are the best experts for indicating the benefits and possible shortcomings of any new ANT. Our goal is to assess the acceptability and usability of the TDS for various tasks that are important in daily lives of these individuals, such as computer access, wheeled mobility, and environmental control.

Interventions

  • PROCEDURE Tongue Piercing
  • DEVICE Usability assessment

Trial Details

FieldValue
Enrollment Target 61 participants
Start Date 2010-05
Est. Completion 2012-03
Phase Phase 1

Sponsor

Georgia Institute of Technology

24 total trials

What the Registry Record Tells You About NCT01124292

The ClinicalTrials.gov registry entry for NCT01124292 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 61 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Georgia Institute of Technology, which has 24 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Tongue Piercing is the first listed.

NCT01124292 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT01124292 about?

NCT01124292 is a clinical study titled "Evaluation of a Tongue Operated Assistive Technology for Individuals With Severe Paralysis". This study was intended to evaluate a new assistive neuro-technology, known as the Tongue Drive System (TDS), by its potential end-users, i.e. individuals with severe disabilities, who are the best experts for indicating the benefits and possible shortcomings of any new ANT. Our goal is to assess th...

What is the current status of trial NCT01124292?

This trial is currently completed. It is a Phase 1 study. The enrollment target is 61 participants. The study started on 2010-05. Estimated completion is 2012-03.

What interventions are being tested in trial NCT01124292?

The interventions under investigation include: Tongue Piercing (PROCEDURE), Usability assessment (DEVICE).

Who is sponsoring clinical trial NCT01124292?

This trial is sponsored by Georgia Institute of Technology, which has 24 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.